Atrial fibrillation: nContact wins FDA clearance for cardiac device

Wed, 01/23/2013 - 5:00am
Mass Device

nContact gets a nod from the FDA for its next-generation cardiac device with added sensing technology.

nContact logo

nContact said it's received FDA clearance for modifications made to its cardiac ablation device.

The Research Triangle Park, N.C.-based device medical device company won 510(k) clearance from the federal watchdog agency for the next generation of its VisiTrax cardiac ablation device, EPi-Sense. The company says this product includes new sensors, generating electrical feedback to assist electrophysiologists with device positioning during cardiac ablation procedures.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.